- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00435474
Malignant Wounds, Wound Treatment, Psycho-Social Support and Relaxation Therapy
Malignant Wounds: A Randomized Clinical Trial Investigating a Complementary Multidimensional Intervention
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective: To investigate whether treatment for cancer patients with malignant wounds can improve (wound healing/wound size, odor, infection, seepage, pain) through comparing the effects of two multidimensional interventions:
- wound treatment (silver product, alginate and foam dressing >< honey product, alginate and foam dressing) in combination with,
- psycho-social support (based on the structure in cognitive therapy) and
- relaxation therapy.
Furthermore to investigate coping strategies, body image, stigma and quality of life in cancer patients with malignant wounds.
Design: A hypothesis testing prospective randomized clinical intervention study (n=70) and an explorative qualitative interview study
Method: Digital photographing, measurement of wound size with Quantify-Image-One, wound morphology registration (the extent of malodour, infection, seepage, bleeding, pain, the healing process), grafting, VAS-score, quality of life questionnaire (EORTC-QLQ-C30, DLQI), Hospital Anxiety and Depression Scale (HAD), Mental Adjustment to Cancer (MAC), interview.
Patients will fill out a diary focusing on wound related problems.
Perspectives: The results will determine whether the honey treatment is an improvement, and whether the silver treatment has statistical and clinical significance.
The qualitative study will contribute new knowledge about conditions of life for cancer patients with cancer wounds, their feelings and impositions.
In spite of proving positive effect, the project will contribute with new required knowledge on treatment and support for cancer patients suffering from malignant wounds.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Rigshospitalet, University hospital of Copenhagen. Oncology department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Cancer with evidence of disease.
- Cancer wound >2 cm.
- Receiving antineoplasm treatment.
- > 18 years.
- Receiving antineoplasm treatment in out-patient clinic.
- Read, speak and write Danish.
Exclusion Criteria:
- No radiation therapy the last 6 month (on the wound).
- Life expectancy > 3 month.
- Not psychotic.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1
Silver product
|
wound treatment (silver product, alginate and foam dressing)
psycho-social support (based on the structure in cognitive therapy)
relaxation therapy
|
|
Experimental: 2
Honey product
|
psycho-social support (based on the structure in cognitive therapy)
relaxation therapy
wound treatment (honey product, alginate and foam dressing)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Wound size
Time Frame: after four weeks intervention period
|
after four weeks intervention period
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Wound odor. Wound infection. Wound exudate. Wound pain. Anxiety and depression. Body-Image.Sexuality.Quality of life.
Time Frame: after the four week intervention period
|
after the four week intervention period
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Lis Adamsen, Professor, Copenhagen University. Faculty of health Sciences, Denmark
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- kf 0102006-5491
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
Morehouse School of MedicineRecruiting
Clinical Trials on Wound treatment
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingObesity | Malignant Breast Neoplasm | Body Mass Index Greater Than or Equal to 30 | Mammoplasty PatientUnited States
-
Miromatrix Medical Inc.Completed
-
Stratpharma AGCompletedWounds and InjuriesUnited States
-
Universidade do PortoUnknownSatisfaction, PersonalPortugal
-
Hillel Yaffe Medical CenterUnknownWounds and InjuriesIsrael
-
University Hospital, AkershusUniversity of Oslo; Ostfold Hospital Trust; South-Eastern Norway Regional Health...RecruitingDiabetic Foot UlcerNorway
-
Dow University of Health SciencesCompleted
-
Central Finland Hospital DistrictUniversity of Eastern Finland; Tampere University HospitalActive, not recruitingWound Heal | Wound | Skin Wound | Skin Scarring | Wound of Skin | Wound Open | Wound BreakdownFinland
-
University of MiamiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedVenous Leg UlcerUnited States
-
University of British ColumbiaUnknownto See Whether Negative Pressure Wound Therapy Decreases Wound Infections.Canada